← FDA Drug Approvals (Drugs@FDA)

LORATADINE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: AUROBINDO PHARMA LTD · Approved 2018-06-29

Drug application

FDA Application #

ANDA208931

Application type

Abbreviated New Drug Application (Generic)

Brand name

LORATADINE

Generic name

LORATADINE ORAL

Active ingredients

LORATADINE

Dosage form

SYRUP

Route

ORAL

Marketing status

Over-the-counter

Sponsor

AUROBINDO PHARMA LTD

Manufacturer

Better Living Brands LLC

First approval

2018-06-29

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown